Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 14 Mar 2023
"You can't treat one of these conditions and ignore the others," says the author of the new review, explaining how obesity can affect the diagnosis and treatment of these heart conditions.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 26, 2025.
Apazunersen, an investigational intrathecal therapy, is being evaluated in the phase 3 Aspire trial for pediatric Angelman syndrome, with study completion anticipated in the second half of 2026.
IgA Nephropathy in 2025: Year in Review
1.
Early palliative care billing up from 2010 to 2019 for advanced cancer
2.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
3.
Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions
4.
Significant differences in breast cancer care still exist, but surgeons can change.
5.
Renewing the call for a national Cancer Patient's Bill of Rights
1.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
2.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
3.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
4.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Thromboprophylaxis In Medical Settings
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge